Sales rise 4.38% to Rs 2829.89 crore
Net profit of Glenmark Pharmaceuticals rose 6.15% to Rs 233.87 crore in the quarter ended March 2021 as against Rs 220.31 crore during the previous quarter ended March 2020. Sales rose 4.38% to Rs 2829.89 crore in the quarter ended March 2021 as against Rs 2711.27 crore during the previous quarter ended March 2020.For the full year,net profit rose 25.02% to Rs 970.09 crore in the year ended March 2021 as against Rs 775.97 crore during the previous year ended March 2020. Sales rose 3.93% to Rs 10806.03 crore in the year ended March 2021 as against Rs 10397.23 crore during the previous year ended March 2020.
ParticularsQuarter EndedYear EndedMar. 2021Mar. 2020% Var.Mar. 2021Mar. 2020% Var.Sales2829.892711.27 4 10806.0310397.23 4 OPM %18.5017.18 -19.2916.33 - PBDT448.59411.35 9 1781.481480.36 20 PBT337.52285.08 18 1337.931063.20 26 NP233.87220.31 6 970.09775.97 25
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
